Motley Fool Asset Management »

Neurocrine Biosciences shares owned by Motley Fool Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Motley Fool Asset Management from 13F filings

Historical chart of Motley Fool Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Motley Fool Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $288k 2.1k 140.11
2024-03-31 $285k 2.1k 137.92
2023-12-31 $246k 1.9k 131.76
2023-09-30 $229k 2.0k 112.50
2022-12-31 $206k 1.7k 119.44
2021-12-31 $4.0k 44 90.91

More positions owned by Motley Fool Asset Management

Microsoft Corp Ordinary Shares (MSFT)
Apple Ordinary Shares (AAPL)
Nvidia Corp Ordinary Shares (NVDA)
Amazon Ordinary Shares (AMZN)
Alphabet Inc Cl C Ordinary Shares (GOOG)
Meta Platforms Ordinary Shares (META)
Axon Enterprise Ordinary Shares (AXON)
Eli Lilly Ordinary Shares (LLY)
Berkshire Hathaway Inc Cl B Ordinary Shares (BRK.B)
Mastercard Ordinary Shares (MA)
Broadcom Ordinary Shares (AVGO)
Costco Whsl Corp Ordinary Shares (COST)
Tesla Ordinary Shares (TSLA)
Watsco Ordinary Shares (WSO)
J P Morgan Chase Ordinary Shares (JPM)

View all positions for Motley Fool Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences